A detailed history of California State Teachers Retirement System transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 122,493 shares of LYEL stock, worth $134,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
122,493
Previous 126,879 3.46%
Holding current value
$134,742
Previous $183,000 7.65%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.13 - $1.88 $4,956 - $8,245
-4,386 Reduced 3.46%
122,493 $169,000
Q2 2024

Aug 14, 2024

SELL
$1.3 - $3.01 $4,812 - $11,143
-3,702 Reduced 2.84%
126,879 $183,000
Q1 2024

May 15, 2024

SELL
$1.71 - $3.07 $16,320 - $29,300
-9,544 Reduced 6.81%
130,581 $291,000
Q4 2023

Feb 13, 2024

SELL
$1.39 - $2.35 $11,773 - $19,904
-8,470 Reduced 5.7%
140,125 $271,000
Q3 2023

Nov 14, 2023

SELL
$1.45 - $3.35 $27,423 - $63,358
-18,913 Reduced 11.29%
148,595 $218,000
Q2 2023

Aug 21, 2023

BUY
$1.89 - $3.86 $195,006 - $398,267
103,178 Added 160.39%
167,508 $532,000
Q1 2023

May 09, 2023

SELL
$1.97 - $3.58 $10,029 - $18,225
-5,091 Reduced 7.33%
64,330 $151,000
Q4 2022

Feb 14, 2023

BUY
$2.78 - $8.09 $3,016 - $8,777
1,085 Added 1.59%
69,421 $240,000
Q3 2022

Nov 18, 2022

SELL
$5.54 - $8.27 $31,323 - $46,758
-5,654 Reduced 7.64%
68,336 $501,000
Q2 2022

Aug 15, 2022

BUY
$3.68 - $6.8 $38,260 - $70,699
10,397 Added 16.35%
73,990 $482,000
Q1 2022

May 16, 2022

BUY
$5.05 - $7.7 $256,661 - $391,344
50,824 Added 398.03%
63,593 $321,000
Q3 2021

Nov 15, 2021

BUY
$11.0 - $17.95 $140,459 - $229,203
12,769 New
12,769 $189,000

Others Institutions Holding LYEL

About Lyell Immunopharma, Inc.


  • Ticker LYEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 247,824,992
  • Market Cap $273M
  • Description
  • Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...
More about LYEL
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.